Stomach News and Research

RSS

Ozempic users continue treatment when weight loss works despite side effects

A study on Ozempic for weight loss reveals user satisfaction is driven by efficacy, despite common gastrointestinal side effects impacting treatment adherence.

13 Feb 2026

Human insight and AI advance prostate cancer treatment

Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY Project offers an intermediate option: precise needle-based diagnostics and targeted therapy powered by AI-driven robotics.

12 Feb 2026

End of enhanced Obamacare subsidies puts tribal health lifeline at risk

Leonard Bighorn said his mother tried for two years to get help for severe stomach pain through the limited health services available near her home on the Fort Peck Reservation in northeastern Montana.

11 Feb 2026

Study reveals how inherited genetic abnormalities raise Barrett’s esophagus risk

Case Western Reserve University researchers have made a significant breakthrough in understanding Barrett's esophagus, a precancerous condition that dramatically increases the risk of developing esophageal adenocarcinoma, one of the fastest-spreading and deadliest forms of cancer.

10 Feb 2026

Mindfulness enables unsedated endoscopy with higher patient satisfaction

A new study has shown that mindfulness helps patients to relax during an endoscopy, allowing doctors to carry out detailed examinations without the need for sedation or general anesthesia.

10 Feb 2026

Long-term omeprazole use linked to mineral imbalance risks

A study conducted in Brazil by researchers at the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC) warns that the prolonged use of proton pump inhibitors (PPIs) can impair nutrient absorption.

9 Feb 2026

Obesity drives one in ten infectious disease deaths

Just over one in 10 deaths from a wide range of infectious diseases can be attributed to obesity worldwide, finds a major new study led by a University College London (UCL) researcher.

9 Feb 2026

Public health workers are quitting over assignments to Guantánamo

Rebekah Stewart, a nurse at the U.S. Public Health Service, got a call last April that brought her to tears. She had been selected for deployment to the Trump administration's new immigration detention operation at Guantánamo Bay, Cuba.

9 Feb 2026

Mycoprotein demonstrates strong potential for sustainable nutrition

Plant-based food as an alternative to meat is high on the agenda today, and mycoprotein (fungal protein) in particular has come into focus in recent years.

6 Feb 2026

Global analysis reveals up to four in ten cancer cases could be prevented

Up to four in ten cancer cases worldwide could be prevented, according to a new global analysis from the World Health Organization (WHO) and its International Agency for Research on Cancer (IARC).

4 Feb 2026

A common diabetes drug may prevent long COVID when taken early

Research supports metformin's efficacy in reducing long COVID symptoms, suggesting its use in acute COVID-19 cases could alleviate long-term health impacts.

3 Feb 2026

Visceral pain: More unpleasant, increases empathy, especially for loved ones

Interoceptive, visceral pain from within the body is perceived more unpleasant than exteroceptive pain from outside the body.

2 Feb 2026

AI tool predicts metastatic risk in multiple cancers

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells remain largely unknown — yet understanding this is crucial for optimizing patient care.

22 Jan 2026

Long-term proton pump inhibitor use not linked to stomach cancer

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds a study of Nordic health data published by The BMJ today.

21 Jan 2026

New oral contrast agent improves bowel disease detection on CT scans

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging oral agent, also known as a "contrast agent," helps radiologists better see bowel structures and disease in CT imaging when compared with the current oral contrast agents.

20 Jan 2026